NCT02748265View on ClinicalTrials.gov

Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 30, 2017

Study Completion Date

December 31, 2018

Conditions
Oxygenation During One Lung Ventilation
Interventions
DRUG

Inhaled Epoprostenol and phenylephrine

After 30 minutes of one-lung ventilation, Epoprostenol 50 ng/kg/min is administered via nebuliser in the anesthesia circuit with phenylephrine administered intravenously

DRUG

Sevoflurane

Volatile maintenance anesthesia

DRUG

Propofol

Intravenous maintenance anesthesia

Trial Locations (1)

B3H 1V7

Toronto General Hospital, 200 Elizabeth St., Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02748265 - Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV) | Biotech Hunter | Biotech Hunter